NBPF3 Activators
The term NBPF3 Activators refers to a speculative group of chemical agents that would be designed to interact with and enhance the activity of the NBPF3 protein, which is a member of the Neuroblastoma Breakpoint Family (NBPF). The NBPF3 gene is one of several within this family that have been identified in the human genome, and like its relatives, the function of NBPF3 is not fully elucidated. Activators for this protein would need to be tailored to its unique structure and activity profile. The structural elucidation of NBPF3 through experimental methods such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, or cryo-electron microscopy would be essential in identifying potential binding sites for these activators. This structural information would be integral to understanding how NBPF3 interacts with other cellular components and how its activity could be modulated by small molecules.
In the theoretical development of NBPF3 Activators, a considerable amount of research would be focused on the chemical and biophysical interactions between the protein and potential activator compounds. High-throughput screening methods might be utilized to assay thousands of chemicals for their ability to bind to and activate NBPF3. Following the identification of preliminary hits, these compounds would undergo a process of optimization to improve their binding characteristics and efficacy in modulating the protein's activity. Computational modeling would play a vital role in this optimization, allowing chemists to predict how alterations to chemical structure might influence interactions with NBPF3. Lead compounds would be synthesized and tested in various in vitro assays, which could involve measuring direct binding, changes in protein conformation, or downstream effects on NBPF3-mediated processes. Through this rigorous process, a set of refined NBPF3 Activators could be generated, providing researchers with precise tools to probe the biological functions of NBPF3 and to expand our understanding of the NBPF protein family.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
As a DNA methyltransferase inhibitor, it could cause demethylation of genes and potentially induce the expression of NBPF3 by altering chromatin structure. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
This phytoestrogen has been shown to possess epigenetic modulating abilities that could impact gene expression, including potentially NBPF3. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Known to affect epigenetic regulation, sulforaphane might modulate histone deacetylase activity, potentially influencing NBPF3 expression. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
It has been suggested to possess epigenetic modulatory properties and may affect gene expression, which could include NBPF3. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
As a polyphenol, it can modulate several signaling pathways and potentially influence the expression of genes like NBPF3. | ||||||
Sodium phenylbutyrate | 1716-12-7 | sc-200652 sc-200652A sc-200652B sc-200652C sc-200652D | 1 g 10 g 100 g 1 kg 10 kg | $77.00 $166.00 $622.00 $5004.00 $32783.00 | 43 | |
This compound is a histone deacetylase inhibitor, which could potentially induce hyperacetylation of histones and affect NBPF3 expression. | ||||||
Zebularine | 3690-10-6 | sc-203315 sc-203315A sc-203315B | 10 mg 25 mg 100 mg | $129.00 $284.00 $1004.00 | 3 | |
A DNA methyltransferase inhibitor that could lead to DNA demethylation and potentially induce expression of the NBPF3 gene. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
As an HDAC inhibitor, vorinostat may relax chromatin structure and promote transcription, possibly affecting NBPF3 expression. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG108 is a non-nucleoside DNA methyltransferase inhibitor, potentially affecting gene expression patterns including NBPF3. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
This DNA methyltransferase inhibitor could lead to the demethylation and activation of gene expression, potentially influencing NBPF3. | ||||||